Stefan Agewall
Overview
Explore the profile of Stefan Agewall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
299
Citations
15195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agewall S
Eur Heart J Cardiovasc Pharmacother
. 2025 Mar;
11(2):105-106.
PMID: 40079901
No abstract available.
2.
Tamargo J, Agewall S, Ambrosio G, Borghi C, Cerbai E, Dan G, et al.
Eur Heart J Cardiovasc Pharmacother
. 2025 Mar;
PMID: 40058879
Despite substantial advances in cardiovascular pharmacotherapy and devices in recent years, prevention and treatment of many cardiovascular diseases (CVD) remain limited, thus reflecting the need for more effective and safer...
3.
Agewall S
Eur Heart J Cardiovasc Pharmacother
. 2025 Jan;
10(8):649-651.
PMID: 39797531
No abstract available.
4.
Fruhwald L, Fasching P, Dobrev D, Kaski J, Borghi C, Wassmann S, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Dec;
11(2):164-173.
PMID: 39719399
This review aims to examine the evidence on the benefits and risks of lipid-lowering drugs in patients with liver disease. Elevated liver enzyme levels often lead to cautious discontinuation of...
5.
Agewall S
Eur Heart J Cardiovasc Pharmacother
. 2024 Nov;
10(7):569-570.
PMID: 39505718
No abstract available.
6.
Agewall S
Eur Heart J Cardiovasc Pharmacother
. 2024 Oct;
10(6):479-480.
PMID: 39364572
No abstract available.
7.
Gigante B, Tamargo J, Agewall S, Atar D, Berg J, Campo G, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Sep;
10(7):614-645.
PMID: 39237457
Obesity and underweight are a growing health problem worldwide and a challenge for clinicians concerning antithrombotic therapy, due to the associated risks of thrombosis and/or bleeding. This clinical consensus statement...
8.
Ni W, Stafoggia M, Zhang S, Ljungman P, Breitner S, Bont J, et al.
J Am Coll Cardiol
. 2024 Sep;
84(13):1149-1159.
PMID: 39230547
Background: Lower air temperature and cold spells have been associated with an increased risk of various diseases. However, the short-term effect of lower air temperature and cold spells on myocardial...
9.
Mayer G, Dobrev D, Kaski J, Semb A, Huber K, Zirlik A, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Aug;
10(7):608-613.
PMID: 39153964
Dyslipidaemia is a common chronic kidney disease (CKD) and contributes to excessively elevated cardiovascular mortality. The pathophysiology is complex and modified by comorbidities like the presence/absence of proteinuria, diabetes mellitus...
10.
Agewall S
Eur Heart J Cardiovasc Pharmacother
. 2024 Aug;
10(5):367-369.
PMID: 39141000
No abstract available.